Cryoport, Inc. (CYRX) |
| 9.95 0.31 (3.22%) 04-14 16:00 |
| Open: | 9.66 |
| High: | 10.26 |
| Low: | 9.66 |
| Volume: | 549,985 |
| Market Cap: | 498(M) |
| PE Ratio: | -11.85 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Integrated Freight & Logistics |
| Sector: | Industrials |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 11.98 |
| Resistance 1: | 10.26 |
| Pivot price: | 8.85 |
| Support 1: | 8.64 |
| Support 2: | 7.64 |
| 52w High: | 11.45 |
| 52w Low: | 5.21 |
Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.
| EPS | -0.840 |
| Book Value | 9.230 |
| PEG Ratio | 0.00 |
| Gross Profit | 1.666 |
| Profit Margin (%) | 44.44 |
| Operating Margin (%) | -0.85 |
| Return on Assets (ttm) | -2.7 |
| Return on Equity (ttm) | -7.5 |
Wed, 08 Apr 2026
Cryoport (CYRX) CEO Jerrell Shelton exercises options, holds 1.13M shares - Stock Titan
Tue, 07 Apr 2026
CryoPort (NASDAQ:CYRX) Stock Crosses Above 200-Day Moving Average - Here's Why - MarketBeat
Tue, 31 Mar 2026
Is It Too Late To Consider Buying Cryoport, Inc. (NASDAQ:CYRX)? - Yahoo Finance
Mon, 30 Mar 2026
Cryoport: Moving Toward Commercial Scalability And Near-Term Breakeven (NASDAQ:CYRX) - Seeking Alpha
Thu, 26 Mar 2026
Vanguard disaggregates holdings; CYRX shows 0 shares after realignment (CYRX) - Stock Titan
Wed, 25 Mar 2026
Cryoport (CYRX) CEO exercises 25,000 options, sells shares for taxes - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |